Shandong Xinhua Pharmaceutical Company Limited reported its monthly return for equity issuer for January 2026. The authorized share capital remained unchanged for its H shares at 195,000,000 shares, each with a par value of RMB 1, while A shares authorized capital rose by 6,906,900 shares to 501,683,435, bringing total authorized capital to RMB 696,683,435.

The issued H shares stayed at 195,000,000 shares. In contrast, A shares grew by 6,906,900 to 501,683,435. According to the report, 6,906,900 A shares were issued under the 2021 Share Option Scheme, raising RMB 48,935,386.5 during the month. At the close of January 2026, 1,155,000 share options remained outstanding under the scheme, following the cancellation of 1,057,000 options.